GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial

M. Gejl; L. Egejord; A. Møller; S. B. Hansen; K. Vang; A. Rodell; H. Brændgaard; H. Gottrup; A. Schacht; N. Møller; B. Brock; J. Rungby; A. Gjedde

doi:10.1007/s00259-015-3198-z

GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial

M. Gejl, L. Egejord, A. Møller, S. B. Hansen, K. Vang, A. Rodell, H. Brændgaard, H. Gottrup, A. Schacht, N. Møller, B. Brock, J. Rungby, A. Gjedde

Department of Neuroscience

Original language	English
Article number	OP322
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	42
Issue number	Suppl 1
Number of pages	2
ISSN	1619-7070
DOIs	https://doi.org/10.1007/s00259-015-3198-z
Publication status	Published - 2015

Access to Document

10.1007/s00259-015-3198-z

Cite this

Gejl, M., Egejord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., Møller, N., Brock, B., Rungby, J., & Gjedde, A. (2015). GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial. European Journal of Nuclear Medicine and Molecular Imaging, 42(Suppl 1), [OP322]. https://doi.org/10.1007/s00259-015-3198-z

GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease : Randomized, placebo-controlled double-blinded clinical trial. / Gejl, M.; Egejord, L.; Møller, A. et al.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, No. Suppl 1, OP322, 2015.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Gejl, M, Egejord, L, Møller, A, Hansen, SB, Vang, K, Rodell, A, Brændgaard, H, Gottrup, H, Schacht, A, Møller, N, Brock, B, Rungby, J & Gjedde, A 2015, 'GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease: Randomized, placebo-controlled double-blinded clinical trial', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. Suppl 1, OP322. https://doi.org/10.1007/s00259-015-3198-z

@article{8b4ed3562a3b4eb8921684165147f424,

title = "GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer{\textquoteright}s Disease: Randomized, placebo-controlled double-blinded clinical trial",

author = "M. Gejl and L. Egejord and A. M{\o}ller and Hansen, {S. B.} and K. Vang and A. Rodell and H. Br{\ae}ndgaard and H. Gottrup and A. Schacht and N. M{\o}ller and B. Brock and J. Rungby and A. Gjedde",

year = "2015",

doi = "10.1007/s00259-015-3198-z",

language = "English",

volume = "42",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer",

number = "Suppl 1",

}

TY - ABST

T1 - GLP-1 analogue liraglutide prevents decline of brain glucose metabolism in Alzheimer’s Disease

T2 - Randomized, placebo-controlled double-blinded clinical trial

AU - Gejl, M.

AU - Egejord, L.

AU - Møller, A.

AU - Hansen, S. B.

AU - Vang, K.

AU - Rodell, A.

AU - Brændgaard, H.

AU - Gottrup, H.

AU - Schacht, A.

AU - Møller, N.

AU - Brock, B.

AU - Rungby, J.

AU - Gjedde, A.

PY - 2015

Y1 - 2015

U2 - 10.1007/s00259-015-3198-z

DO - 10.1007/s00259-015-3198-z

M3 - Conference abstract in journal

SN - 1619-7070

VL - 42

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - Suppl 1

M1 - OP322

ER -